Amarin Corp Plc (AMRN)

[sts66]

I think the train is leaving the station and it might pick up speed pretty fast as I see the street taking it back to $17s before readout of topline results.

Well, you wrote that at 2 in the afternoon, so I'll assume you weren't drunk.....but given current price action, the flood of "fish oil doesn't work" crap, and knowledge of past treatment of AMRN by FDA, there's no chance in hell we see double digits before results are released, let alone hit $17. Might not even hit $17 *after* initial results come out if the starting point isn't double or triple where we are right now, unless the PE RRR is mind blowing (15% alone ain't gonna do it), but throw in a high SE RRR of CV death and it might get there.

Like BB keeps saying, this is a damaged stock and an image damaged company, and he's right - AMRN doesn't have the fresh bloom of a MDGL type biotech anymore - even with them, there was barely a runup into their release of 12 wk P2 NASH results, and it actually sold off in advance of the 36 wk P2 liver biopsy results that shot it from $100 to $325.